Medicine recalls
|
| |
| Canada: One lot of Verkazia (cyclosporine) eye drops recalled due to potential presence of particulate matter |
| |
Health Canada announces that McKesson Specialized Distribution is recalling one lot (1N81H) of Verkazia (cyclosporine) eye drops after certain vials from the lot were found to contain particulate matter. The manufacturer, Santen Inc., determined the particles were a crystalized form of the active drug ingredient, cyclosporine. The particulate matter may irritate the surface of the eye. Solidified cyclosporine may also reduce the concentration of the drug in the solution, which may reduce the treatment’s effectiveness.
McKesson Specialized Distribution, also recalled one lot (1N80H) of Verkazia in August 2021 due to the potential presence of particulate matter, which was identified during routine testing. Santen Inc. continues to investigate the cause of this issue and will report its findings to Health Canada.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/one-lot-verkazia-cyclosporine-eye-drops-recalled-due-potential-presence-particulate
In Hong Kong, Ikervis Eye Drops, Emulsion 1mg/ml (HK-65076) is a cyclosporine-containing pharmaceutical product registered by Santen Pharmaceutical (Hong Kong) Limited (Santen), and is a prescription-only medicine. As confirmed with Santen, the affected batch has not been imported into Hong Kong. Related news was previously issued by various overseas drug regulatory authorities, and was posted on the Drug Office website on 27 Aug 2021, 2 Sep 2021 and 16 Sep 2021 respectively.
Ends/Saturday, Nov 13, 2021
Issued at HKT 13:00
|
| |
|
